Researcher.Life Logo

International Journal of Clinical Pharmacy : Impact Factor & More

eISSN: 2210-7711pISSN: 2210-7703

Aims and Scope of International Journal of Clinical Pharmacy

The International Journal of Clinical Pharmacy is a bimonthly peer-reviewed medical journal covering all aspects of clinical pharmacy and related practice-oriented subjects. It was established in 1965 and is published by Springer Science+Business Media.. The editor-in-chief is J. W.F. van Mil. The journal was called Pharmacy World & Science until 2010. According to the Journal Citation Reports, the journal has a 2014 impact factor of 1.348. Less

Key Metrics

CiteScore
3.3
Impact Factor
< 5
SJR
Q3Pharmacy
SNIP
1.09
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Clinical Pharmacy

International Journal of Clinical Pharmacy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Journal of Clinical Pharmacy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Clinical Pharmacy

Comment on "evaluation ofhigh dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation".
  • 15 Apr 2026
  • International journal of clinical pharmacy
Authors' response to comment on evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Evaluating the impact of pharmacists in outpatient mental health settings: a systematic review.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Cost-effectiveness of toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China and the United States healthcare systems.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Evolution of community pharmacy services in the European Union and beyond: a cross-country survey of 33 national pharmacy organisations.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Evaluation of consistency in adverse event reporting between trial registry and publications in COVID-19 pharmacological intervention trials.
  • 13 Apr 2026
  • International journal of clinical pharmacy
Comment on "evaluation ofhigh dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation".
  • 15 Apr 2026
  • International journal of clinical pharmacy
Authors' response to comment on evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Evaluating the impact of pharmacists in outpatient mental health settings: a systematic review.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Cost-effectiveness of toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China and the United States healthcare systems.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Evolution of community pharmacy services in the European Union and beyond: a cross-country survey of 33 national pharmacy organisations.
  • 15 Apr 2026
  • International journal of clinical pharmacy
Evaluation of consistency in adverse event reporting between trial registry and publications in COVID-19 pharmacological intervention trials.
  • 13 Apr 2026
  • International journal of clinical pharmacy

FAQs on International Journal of Clinical Pharmacy